← Back to Search

Treatment for Coronary Artery Disease (PROGRESS-CTO Trial)

N/A
Waitlist Available
Led By Emmanouil S Brilakis, MD, PhD
Research Sponsored by Minneapolis Heart Institute Foundation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* Patients undergoing CTO PCI at each of the participating centers.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up discharge from the hospital after pci, which usually happens the day after the procedure
Awards & highlights

Summary

Percutaneous coronary intervention (PCI) of chronic total occlusions (CTOs) is increasingly being performed in patients with advanced coronary artery disease, but there is limited information on the techniques utilized and the procedural outcomes. The goal of this multicenter, investigator initiated registry is to collect information on treatment strategies and outcomes of consecutive patients undergoing CTO PCI among various participating centers. The information collected will be used to determine the frequency of CTO PCI performed at the participating sites and examine the procedural strategies utilized, and the procedural (both immediate and during follow-up) outcomes.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~discharge from the hospital after pci (which usually happens the day after the procedure) and during clinically-indicated follow-up. there are no pre-specified follow-up time periods - patients are assessed if and when they come to receive clinical care.
This trial's timeline: 3 weeks for screening, Varies for treatment, and discharge from the hospital after pci (which usually happens the day after the procedure) and during clinically-indicated follow-up. there are no pre-specified follow-up time periods - patients are assessed if and when they come to receive clinical care. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
procedural success of chronic total occlusion PCI
Secondary outcome measures
major adverse cardiovascular events
technical success of chronic total occlusion PCI

Find a Location

Who is running the clinical trial?

Minneapolis Heart Institute FoundationLead Sponsor
30 Previous Clinical Trials
13,636 Total Patients Enrolled
7 Trials studying Coronary Artery Disease
8,403 Patients Enrolled for Coronary Artery Disease
Emmanouil S Brilakis, MD, PhDPrincipal InvestigatorMinneapolis Heart Institute Foundation
16 Previous Clinical Trials
1,057 Total Patients Enrolled
6 Trials studying Coronary Artery Disease
349 Patients Enrolled for Coronary Artery Disease
~146 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top